Key Developments: PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

35.07USD
1 Aug 2013
Price Change (% chg)

$0.98 (+2.87%)
Prev Close
$34.09
Open
$34.32
Day's High
$35.09
Day's Low
$34.07
Volume
321,285
Avg. Vol
271,282
52-wk High
$35.86
52-wk Low
$24.71

Search Stocks

Latest Key Developments (Source: Significant Developments)

PerkinElmer Inc Reaffirms FY 2013 Revenue Guidance; Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
Thursday, 1 Aug 2013 04:05pm EDT 

PerkinElmer Inc announced that for fiscal 2013, it forecasts organic revenue to increase in the low-single digit range relative to fiscal 2012, GAAP earnings per share from continuing operations in the range of $1.40 to $1.47 and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, and updates adjusted earnings per share (EPS) to a range of $2.03 to $2.10 from a range of $2.00 to $2.10. The Company reported revenues of $2.141 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.162 billion and EPS of $2.04 for fiscal 2013.  Full Article

PerkinElmer Inc Declares Quarterly Dividend
Friday, 26 Jul 2013 04:05pm EDT 

PerkinElmer Inc announced that it has declared a regular quarterly dividend of $0.07 per share of common stock on July 26, 2013. This dividend is payable on November 8, 2013, to all shareholders of record at the close of business on October 18, 2013.  Full Article

PerkinElmer Inc's PerkinElmer Health Sciences, Inc. Announces Sale Of Facility To Senior Housing Properties Trust-Form 8-K
Monday, 22 Jul 2013 04:07pm EDT 

PerkinElmer Inc reported in its Form 8-K that on July 18, 2013, PerkinElmer Health Sciences, Inc. (PerkinElmer Health Sciences), an indirect wholly owned subsidiary of PerkinElmer, Inc., entered into a purchase and sale agreement for the sale of the PerkinElmer Health Sciences’ facility located at 549 Albany Street, Boston, Massachusetts (Property) for $49.5 million to Senior Housing Properties Trust. Under the terms of the Agreement, simultaneously with the closing of the sale of the Property, PerkinElmer Health Sciences will enter into a lease agreement with Senior Housing Properties Trust or its designee whereby PerkinElmer Health Sciences will lease back the Property for its continued use as an office, laboratory, production and distribution facility. The Lease has an initial term of 15 years commencing upon the execution of the Lease. Pursuant to the terms of the Lease, PerkinElmer Health Sciences will pay an initial base annual rent of $3.1 million. After the first year of the Lease, the base rental amount will increase annually by 2.25%. PerkinElmer Health Sciences has the right to extend the term of the Lease for two additional periods of ten years each. These transactions are subject to customary closing conditions, including satisfactory completion of a due diligence period, and are expected to close in the third quarter of 2013.  Full Article

PerkinElmer Inc Declares Quarterly Dividend
Thursday, 13 Jun 2013 04:05pm EDT 

PerkinElmer Inc announced that Board of Directors declared a regular quarterly dividend of $0.07 per share of common stock on June 13, 2013. This dividend is payable on August 9, 2013, to all shareholders of record at the close of business on July 19, 2013.  Full Article

PerkinElmer Inc Lowers FY 2013 Guidance
Thursday, 25 Apr 2013 04:21pm EDT 

PerkinElmer Inc updated its fiscal 2013 guidance and expects organic revenue to increase in the low-single digit range relative to fiscal 2012 and GAAP earnings per share (EPS)from continuing operations in the range of $1.30 to $1.40 and on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share in the range of $2.00 to $2.10. The Company reported revenues of $2.14 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.24 billion and EPS of $2.29 for fiscal 2013.  Full Article

PerkinElmer Inc Issues FY 2013 Guidance In Line With Analysts' Estimates
Thursday, 31 Jan 2013 04:05pm EST 

PerkinElmer Inc announced that for fiscal 2013, it expects organic revenue to increase in the mid-single digit range relative to fiscal 2012, GAAP earnings per share from continuing operations in the range of $1.57-$1.65 and adjusted earnings per share to $2.24-$2.32. The Company reported revenues of $2.14 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.24 billion and EPS of $2.32 for fiscal 2013.  Full Article

PerkinElmer Inc Declares Quarterly Dividend
Friday, 25 Jan 2013 04:05pm EST 

PerkinElmer Inc announced that it has declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.  Full Article

PerkinElmer Inc And Verinata Health, Inc Announces Collaboration
Wednesday, 9 Jan 2013 08:02am EST 

PerkinElmer Inc and Verinata Health, Inc., announced a strategic agreement for expanding access to Verinata's verifi test, the comprehensive non-invasive prenatal test (NIPT) currently available for high-risk pregnancies. The verifi test, which is performed at Verinata's CLIA-certified, California laboratory, uses a single maternal blood draw as early as 10 weeks of pregnancy to detect multiple fetal chromosomal aneuploidies. Chromosomal aneuploidy is an abnormal number of chromosomes. Under the terms of the collaboration agreement, PerkinElmer will serve as an exclusive Verinata Health commercial partner in the joint sales and marketing of the verifi test in the United States. The collaboration consolidates and streamlines delivery of prenatal testing options due to the combination of PerkinElmer's prenatal testing menu with Verinata's technologies for the early, non-invasive identification of specific fetal chromosomal aneuploidies.  Full Article

PerkinElmer Inc Reaffirms FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance
Thursday, 25 Oct 2012 04:05pm EDT 

PerkinElmer Inc announced that for fiscal 2012, it expects organic revenue to increase in the mid-single digit range relative to fiscal 2011, GAAP earnings per share from continuing operations in the range of $1.22-$1.24 and adjusted earnings per share to $2.05-$2.07. The Company reported revenues of $1.95 billion in fiscal 2011. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.12 billion and EPS of $2.05 for fiscal 2012.  Full Article

PerkinElmer Inc Declares Quarterly Dividend
Wednesday, 24 Oct 2012 04:05pm EDT 

PerkinElmer Inc announced that the Board of Directors declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2012. This dividend is payable on February 8, 2013, to all shareholders of record at the close of business on January 18, 2013.  Full Article

PerkinElmer lower profit exceeds Street expectations

- PerkinElmer Inc on Thursday reported lower second-quarter earnings that exceeded tempered expectations after Wall Street had been caught off guard by a disappointing first quarter.

Search Stocks